SFE Investment Counsel Has $332,000 Holdings in Zoetis Inc. $ZTS

SFE Investment Counsel cut its position in shares of Zoetis Inc. (NYSE:ZTS) by 80.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,615 shares of the company’s stock after selling 19,266 shares during the quarter. SFE Investment Counsel’s holdings in Zoetis were worth $332,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in ZTS. Louisiana State Employees Retirement System acquired a new stake in Zoetis during the 1st quarter valued at $2,542,000. Deutsche Bank AG boosted its position in shares of Zoetis by 19.1% in the fourth quarter. Deutsche Bank AG now owns 5,558,183 shares of the company’s stock worth $699,331,000 after buying an additional 891,921 shares during the period. Pincus Capital Management LP acquired a new stake in shares of Zoetis in the fourth quarter worth $2,109,000. Highbridge Capital Management LLC purchased a new position in shares of Zoetis during the fourth quarter valued at $7,004,000. Finally, Pacer Advisors Inc. grew its holdings in shares of Zoetis by 16.7% during the first quarter. Pacer Advisors Inc. now owns 165,570 shares of the company’s stock valued at $19,572,000 after buying an additional 23,687 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on ZTS shares. BNP Paribas Exane reduced their price objective on Zoetis from $146.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday, August 11th. Piper Sandler lowered their target price on Zoetis from $90.00 to $80.00 and set a “neutral” rating on the stock in a research note on Monday, August 10th. William Blair reiterated a “market perform” rating on shares of Zoetis in a report on Thursday, August 6th. Stifel Nicolaus reduced their price target on shares of Zoetis from $95.00 to $85.00 and set a “hold” rating for the company in a research report on Friday, June 26th. Finally, Weiss Ratings cut shares of Zoetis from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, June 12th. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $109.62.

Zoetis Trading Down 2.9%

NYSE ZTS opened at $73.64 on Friday. The company has a current ratio of 3.08, a quick ratio of 1.84 and a debt-to-equity ratio of 2.87. Zoetis Inc. has a 1-year low of $71.45 and a 1-year high of $160.48. The firm’s fifty day simple moving average is $76.30 and its 200-day simple moving average is $99.01. The company has a market capitalization of $30.43 billion, a PE ratio of 12.13, a price-to-earnings-growth ratio of 1.28 and a beta of 0.74.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.02. Zoetis had a return on equity of 74.89% and a net margin of 27.49%.The firm had revenue of $2.47 billion during the quarter, compared to analysts’ expectations of $2.50 billion. During the same quarter last year, the firm earned $1.76 earnings per share. The business’s revenue for the quarter was down .2% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. As a group, sell-side analysts anticipate that Zoetis Inc. will post 6.19 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, July 20th. Zoetis’s payout ratio is currently 34.93%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.